Methoden vergleichen
Prüfen Sie die ausgewählten Methoden nebeneinander; abweichende Zeilen sind hervorgehoben.
| Mattis Dementia Rating Scale× | Trail Making Test× | |
|---|---|---|
| Fachgebiet | Neuropsychologie | Neuropsychologie |
| Familie | Process / pipeline | Process / pipeline |
| Entstehungsjahr≠ | 1988 | 1958 |
| Urheber≠ | Sandra Mattis | Ralph Reitan |
| Typ≠ | Clinician-administered comprehensive neuropsychological scale | Clinician-administered neuropsychological test of attention and executive function |
| Wegweisende Quelle≠ | Mattis, S. (1988). Dementia Rating Scale (DRS). Odessa, FL: Psychological Assessment Resources. link ↗ | Reitan, R. M. (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Perceptual and Motor Skills, 8(3), 271-276. DOI ↗ |
| Aliasnamen≠ | DRS, Mattis DRS, Dementia Rating Scale | TMT, Trails A, Trails B, Trail Making A |
| Verwandt | 5 | 5 |
| Zusammenfassung≠ | The Mattis Dementia Rating Scale (DRS) is a comprehensive 36-item clinician-administered neuropsychological battery designed to assess and quantify cognitive decline in dementia. Developed by Sandra Mattis in 1988, the DRS measures five major cognitive domains—attention, initiation/perseveration, construction, conceptualization, and memory—and provides both a total score and subscale scores. The DRS is particularly valued in neurodegenerative disease research and clinical settings for its sensitivity to cognitive change over time and its utility in detecting cognitive impairment across the dementia spectrum. | The Trail Making Test (TMT) is a simple, brief neuropsychological test developed by Reitan in 1958 that measures visuomotor processing speed, attention, and executive function. The TMT comprises two forms: Part A, which assesses basic processing speed and visual scanning, and Part B, which assesses executive function, task-switching, and cognitive flexibility. Despite its simplicity, the TMT is highly sensitive to cognitive impairment across a wide range of neurological and psychiatric conditions and remains one of the most widely used screening tests in neuropsychology. |
| ScholarGateDatensatz ↗ |
|
|